Squarepoint’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$365K Buy
294,584
+215,006
+270% +$267K ﹤0.01% 2068
2025
Q1
$93.9K Buy
79,578
+69,400
+682% +$81.9K ﹤0.01% 2534
2024
Q4
$18.6K Sell
10,178
-32,862
-76% -$60.1K ﹤0.01% 2712
2024
Q3
$73.2K Sell
43,040
-481,568
-92% -$819K ﹤0.01% 2393
2024
Q2
$719K Buy
+524,608
New +$719K ﹤0.01% 1537
2023
Q4
Sell
-247,861
Closed -$2.07M 2827
2023
Q3
$2.07M Buy
247,861
+148,917
+151% +$1.24M 0.01% 954
2023
Q2
$1.32M Buy
+98,944
New +$1.32M ﹤0.01% 1109
2023
Q1
Sell
-310,800
Closed -$2.54M 2633
2022
Q4
$2.54M Sell
310,800
-341,602
-52% -$2.79M 0.01% 692
2022
Q3
$3.79M Sell
652,402
-204,145
-24% -$1.19M 0.02% 549
2022
Q2
$3.79M Buy
856,547
+37,077
+5% +$164K 0.02% 510
2022
Q1
$7.46M Buy
819,470
+800,175
+4,147% +$7.28M 0.03% 370
2021
Q4
$395K Sell
19,295
-357,381
-95% -$7.32M ﹤0.01% 1740
2021
Q3
$9.62M Buy
376,676
+336,247
+832% +$8.59M 0.03% 301
2021
Q2
$1.41M Buy
40,429
+6,907
+21% +$242K 0.01% 972
2021
Q1
$1.12M Sell
33,522
-24,398
-42% -$813K 0.01% 1008
2020
Q4
$1.5M Buy
+57,920
New +$1.5M 0.01% 866
2020
Q3
Sell
-75,635
Closed -$261K 2587
2020
Q2
$261K Buy
+75,635
New +$261K ﹤0.01% 1641
2020
Q1
Sell
-191,776
Closed -$986K 2289
2019
Q4
$986K Buy
191,776
+159,300
+491% +$819K 0.01% 1315
2019
Q3
$168K Sell
32,476
-187,191
-85% -$968K ﹤0.01% 2016
2019
Q2
$1.33M Sell
219,667
-20,693
-9% -$125K 0.01% 1079
2019
Q1
$1.74M Sell
240,360
-25,174
-9% -$182K 0.02% 834
2018
Q4
$1.97M Buy
+265,534
New +$1.97M 0.02% 669
2018
Q1
Sell
-14,977
Closed -$40K 2011
2017
Q4
$40K Buy
+14,977
New +$40K ﹤0.01% 2017
2016
Q4
Sell
-13,097
Closed -$117K 1885
2016
Q3
$117K Buy
+13,097
New +$117K 0.01% 945
2016
Q1
Sell
-15,100
Closed -$198K 1376
2015
Q4
$198K Buy
+15,100
New +$198K 0.02% 1002
2015
Q1
Sell
-22,400
Closed -$176K 481
2014
Q4
$176K Buy
+22,400
New +$176K 0.17% 178